Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 188

The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.

STAT 3 the oncogene – still eluding therapy?

Wake, Matthew S., Watson, Christine J.·2015·The FEBS Journal

Abstract

The STAT family of transcription factors (signal transducers and activators of transcription) transduce signals from cytokine receptors to the nucleus, where STAT dimers bind to DNA and regulate transcription. STAT 3 is the most ubiquitous of the STAT s, being activated by a wide variety of cytokines and growth factors. STAT 3 has many roles in physiological processes such as inflammatory signalling, aerobic glycolysis and immune suppression, and was also the first family member shown to be aberrantly activated in a wide range of both solid and liquid tumours. STAT 3 promotes tumorigenesis by regulating the expression of various target genes, including cell‐cycle regulators, angiogenic factors and anti‐apoptosis genes. Paradoxically, in some circumstances, STAT 3 signalling induces cell death. The best known example is the involuting mammary gland, where STAT 3 is essential for induction of a lysosomal pathway of cell death. Nevertheless, direct silencing or inhibition of STAT 3 diminishes tumour growth and survival in both animal and human studies. This suggests that abolishing STAT 3 activity may be an effective cancer therapeutic strategy. However, despite this potential as a therapeutic target, and the extensive attempts by many laboratories and pharmaceutical companies to develop an effective STAT 3 inhibitor for use in the clinic, no direct STAT 3 inhibitor has been approved for clinical use. In this review, we focus on the role of STAT 3 in tumorigenesis, and discuss its potential as a therapeutic target for cancer treatment.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/febs.13285

Cites

14 of 14 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 14 references

Cited by

See all 188

Metadata

Authors
Wake, M. S., & Watson, C. J.
Venue
The FEBS Journal
Publisher
Wiley
Published
2015-04-22
Volume
282
Issue
14
Pages
2600-2611
ISSN
  • 1742-464X (ISSN-L)
  • 1742-4658
OpenAlex
W2028792884
Cited by
188
References
14
FWCI
11.31
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: STAT 3 the oncogene – still eluding therapy? https://app.cochat.ai/papers/10.1111/febs.13285
The paper
Wake, M. S., & Watson, C. J. (2015). STAT 3 the oncogene – still eluding therapy? The FEBS Journal. https://doi.org/10.1111/febs.13285

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.